ELOX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2019-11-06 compared with 2019-08-07 · 2 added, 4 removed, 28 unchanged (18% of the section changed)
6 unchanged sentences
Exhibit Description
−Removed: Underwriting Agreement, dated as of June 20, 2019, by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc.
−Removed: and Piper Jaffray & Co..
−Removed: June 21, 2019
+Added: Change in Control Severance Benefit Plan
Certification of the Company’s Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities and Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
ELOXX PHARMACEUTICALS, INC.
−Removed: August 7, 2019
+Added: November 6, 2019
/s/ Gregory Weaver
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.